WEBVTT - Is Pfizer's Vaccine Plan Fair?

0:00:00.880 --> 0:00:05.520
<v Speaker 1>Welcome to Prognosis. I'm Laura Carlson. It's day three hundred

0:00:05.559 --> 0:00:09.760
<v Speaker 1>and fifty six since coronavirus was declared a global pandemic.

0:00:10.880 --> 0:00:15.680
<v Speaker 1>Today's main story. Demand for the Fiser vaccine from everywhere

0:00:15.720 --> 0:00:20.720
<v Speaker 1>in the world far outstrips supply. That means the company

0:00:20.760 --> 0:00:23.840
<v Speaker 1>has made tough decisions about how much to supply to

0:00:24.000 --> 0:00:29.040
<v Speaker 1>different countries, and many world leaders aren't happy about the

0:00:29.080 --> 0:00:34.360
<v Speaker 1>way they've done it. But first, here's what happened in

0:00:34.479 --> 0:00:43.040
<v Speaker 1>virus news today. People in the US are warming to

0:00:43.080 --> 0:00:47.000
<v Speaker 1>the idea of getting a vaccine. A Pew Research poll

0:00:47.200 --> 0:00:51.320
<v Speaker 1>shows COVID nineteen vaccine hesitancy in the country is ebbing,

0:00:52.400 --> 0:00:56.160
<v Speaker 1>But the same study shows that partisan differences in people's

0:00:56.240 --> 0:01:02.480
<v Speaker 1>intention to get vaccinated is widening. In November, thirty nine

0:01:02.520 --> 0:01:06.520
<v Speaker 1>percent of people said they probably or definitely wouldn't get

0:01:06.520 --> 0:01:12.080
<v Speaker 1>a shot. That number declined to thirty percent in February.

0:01:12.640 --> 0:01:17.960
<v Speaker 1>About three quarters agree that widespread vaccination would help the economy.

0:01:18.400 --> 0:01:22.240
<v Speaker 1>The Republicans are less prone to that view than Democrats.

0:01:24.880 --> 0:01:28.720
<v Speaker 1>The vaccine, being developed by Astra Zenica and Oxford University,

0:01:28.760 --> 0:01:32.560
<v Speaker 1>appears to protect against the Brazilian variant of the disease.

0:01:33.520 --> 0:01:36.640
<v Speaker 1>A person familiar with the matter told Reuters the shot

0:01:36.720 --> 0:01:39.640
<v Speaker 1>will not need to be modified to protect against the

0:01:39.680 --> 0:01:44.120
<v Speaker 1>Brazil P one variant. Results come from a study by

0:01:44.160 --> 0:01:49.280
<v Speaker 1>Oxford University that has not yet been made public. Finally,

0:01:49.840 --> 0:01:55.280
<v Speaker 1>Canada's Public Health Agency licensed Johnson and Johnson's coronavirus vaccine,

0:01:55.920 --> 0:02:00.400
<v Speaker 1>making it the fourth shot available in the country. Anada

0:02:00.560 --> 0:02:03.000
<v Speaker 1>is struggling to keep up with its group of seven

0:02:03.000 --> 0:02:08.600
<v Speaker 1>peers on inoculations. Canada has an agreement to purchase thirty

0:02:08.639 --> 0:02:12.600
<v Speaker 1>eight million shots from the New Jersey based company. The

0:02:12.639 --> 0:02:15.960
<v Speaker 1>one dose J and J shot could help Prime Minister

0:02:16.160 --> 0:02:20.480
<v Speaker 1>Justin Trudeau achieve his target of vaccinating every Canadian that

0:02:20.600 --> 0:02:30.560
<v Speaker 1>wants one by September. And now, for today's main story,

0:02:32.360 --> 0:02:36.520
<v Speaker 1>vaccine distribution still has the feel of a zero sum game.

0:02:37.600 --> 0:02:41.640
<v Speaker 1>Five days after Israel received seven hundred thousand doses of

0:02:41.639 --> 0:02:45.920
<v Speaker 1>the Fiser bio and Tech vaccine, Fiser told other non

0:02:46.080 --> 0:02:49.200
<v Speaker 1>u as customers that it would cut supplies while it

0:02:49.320 --> 0:02:54.079
<v Speaker 1>briefly closed a facility in Belgium. The disparity in vaccine

0:02:54.080 --> 0:02:57.840
<v Speaker 1>allocation is the product of a company struggling to apportion

0:02:57.919 --> 0:03:04.280
<v Speaker 1>doses while demand our exceeds supply. I spoke with Stephanie

0:03:04.320 --> 0:03:08.560
<v Speaker 1>Baker and Cynthia Coons, who reported for Bloomberg Business Week

0:03:08.919 --> 0:03:12.080
<v Speaker 1>that the company has determined how many doses a country

0:03:12.120 --> 0:03:16.400
<v Speaker 1>gets through an opaque process that appears to involve a

0:03:16.440 --> 0:03:20.800
<v Speaker 1>mix of border size, position in the queue, production forecasts,

0:03:21.120 --> 0:03:25.000
<v Speaker 1>calls from world leaders, and of course, the desire to

0:03:25.040 --> 0:03:30.000
<v Speaker 1>make a profit. Vaccine programs have begun to roll out

0:03:30.040 --> 0:03:33.320
<v Speaker 1>in earnest throughout the US and across much of Europe.

0:03:33.639 --> 0:03:38.760
<v Speaker 1>Many states are discussing opening eligibility to younger and younger demographics,

0:03:38.760 --> 0:03:42.720
<v Speaker 1>but many still are awaiting their first shots. Now, this

0:03:42.800 --> 0:03:47.480
<v Speaker 1>situation is a pretty stark contrast to what's happening in Israel,

0:03:47.520 --> 0:03:50.280
<v Speaker 1>for example, which you know, currently holds the record of

0:03:50.320 --> 0:03:54.240
<v Speaker 1>having administered the most COVID vaccine doses per capita than

0:03:54.480 --> 0:03:57.640
<v Speaker 1>any other country in the world. And just to start

0:03:57.680 --> 0:04:01.400
<v Speaker 1>off with, you know, what are some of the factors

0:04:01.440 --> 0:04:08.920
<v Speaker 1>that have accounted for Israel's incredibly accelerated vaccine distribution. You know, Israel,

0:04:09.080 --> 0:04:11.560
<v Speaker 1>of course has been a world leader in vaccination, and

0:04:11.600 --> 0:04:14.720
<v Speaker 1>that is in part due to fiser Uh and the

0:04:14.800 --> 0:04:19.680
<v Speaker 1>deal that Israeli's Prime Minister Benjamin Nettiyah, who struck with

0:04:20.400 --> 0:04:26.440
<v Speaker 1>Visor's CEO Albert Borla. Israel was prioritized for two reasons.

0:04:26.480 --> 0:04:31.159
<v Speaker 1>Really one um it paid more, paid almost thirty dollars

0:04:31.160 --> 0:04:34.720
<v Speaker 1>a dose, which was about fifty more than the US paid.

0:04:34.880 --> 0:04:38.640
<v Speaker 1>And to it, it offered to almost exclusively use the

0:04:38.640 --> 0:04:42.560
<v Speaker 1>Fiser vaccine in order to generate a real world effectiveness

0:04:42.600 --> 0:04:45.279
<v Speaker 1>study to show how the vaccine works in a much

0:04:45.360 --> 0:04:49.880
<v Speaker 1>larger group of people than in the control controlled trials.

0:04:50.080 --> 0:04:53.640
<v Speaker 1>And this has generated a stream of positive headlines about

0:04:53.640 --> 0:04:57.520
<v Speaker 1>how effective the Visor vaccine is, which has only helped

0:04:57.640 --> 0:05:02.960
<v Speaker 1>Fiser as its um marketed at the COVID vaccine worldwide UM.

0:05:03.040 --> 0:05:06.240
<v Speaker 1>And it came at a time when europe um was

0:05:06.480 --> 0:05:11.240
<v Speaker 1>being short changed with vaccines because Visor needed to shut

0:05:11.279 --> 0:05:16.200
<v Speaker 1>down its Belgian production facility in order to boost production

0:05:16.279 --> 0:05:19.440
<v Speaker 1>long term. But that that shutdown lasted for about two weeks,

0:05:19.480 --> 0:05:24.279
<v Speaker 1>and you know, while Israel was being supplied with millions

0:05:24.279 --> 0:05:28.039
<v Speaker 1>of doses of vaccines europe, European supplies were cut and

0:05:28.120 --> 0:05:33.600
<v Speaker 1>you know that had a huge effect on Europe's vaccine rollout. Now, Stephanie,

0:05:33.720 --> 0:05:38.760
<v Speaker 1>you mentioned Viser CEO Albert Borla, and I'm wondering what

0:05:39.400 --> 0:05:44.920
<v Speaker 1>specifically his role was in this negotiation of vaccine supply

0:05:45.360 --> 0:05:49.520
<v Speaker 1>and kind of an accelerated timeline with regard to israel I. Mean,

0:05:49.839 --> 0:05:54.520
<v Speaker 1>what overall does he have control over when when kind

0:05:54.520 --> 0:05:59.599
<v Speaker 1>of negotiating which countries will receive Visor's vaccine first and

0:05:59.600 --> 0:06:02.800
<v Speaker 1>and the wanted to use will receive. You know, that's

0:06:02.839 --> 0:06:06.640
<v Speaker 1>a good question. You know, he told us that UM,

0:06:06.720 --> 0:06:11.440
<v Speaker 1>he was more focused on UM the scientific efforts to

0:06:11.839 --> 0:06:17.920
<v Speaker 1>develop a new COVID vaccine against the new variants and

0:06:17.960 --> 0:06:21.240
<v Speaker 1>some of the scientific developments on make it easier to

0:06:21.760 --> 0:06:24.760
<v Speaker 1>store Visor's vaccine, which needs to be kept at sub

0:06:25.000 --> 0:06:28.839
<v Speaker 1>arctic temperatures. But at the same time, during the past

0:06:28.880 --> 0:06:32.600
<v Speaker 1>six months he turned into this kind of quasi statesman,

0:06:33.279 --> 0:06:38.479
<v Speaker 1>holding talks with world leaders UM, including you know, he

0:06:38.560 --> 0:06:42.040
<v Speaker 1>spoke to Israeli's Prime Minister Benjamin Natanya, who more than

0:06:42.080 --> 0:06:46.480
<v Speaker 1>twenty times, and Natanya who bragged that he was able

0:06:46.680 --> 0:06:51.039
<v Speaker 1>to get Borla to take his call even at two am. UM.

0:06:51.120 --> 0:06:53.800
<v Speaker 1>He went on to have you know, talks with the

0:06:53.839 --> 0:06:59.080
<v Speaker 1>European Commission President Ursula vonder lyand who called and complained

0:06:59.240 --> 0:07:04.479
<v Speaker 1>when FISER announced its cut. In mid January, he had

0:07:04.680 --> 0:07:09.120
<v Speaker 1>talks with UH, the Canadian leader Justin Trudeau, who was

0:07:09.160 --> 0:07:12.600
<v Speaker 1>also upset that Canada had been cut um. You know,

0:07:12.640 --> 0:07:17.080
<v Speaker 1>so he occupies this very uh strange position right now

0:07:17.120 --> 0:07:20.480
<v Speaker 1>where he's the CEO of a pharma giant, but you know,

0:07:20.640 --> 0:07:24.800
<v Speaker 1>he is involved in politics, um, whether he likes it

0:07:24.880 --> 0:07:29.040
<v Speaker 1>or not. And of course this effort in Israel came

0:07:29.080 --> 0:07:32.440
<v Speaker 1>out of crucial time for Netan Yahoo, who was facing

0:07:32.920 --> 0:07:36.720
<v Speaker 1>re election in March um and it's very much positioned

0:07:36.840 --> 0:07:41.360
<v Speaker 1>his COVID vaccination campaign as part of his political campaign,

0:07:42.080 --> 0:07:46.600
<v Speaker 1>and you know, arguably has boosted his chances of re election.

0:07:47.360 --> 0:07:51.640
<v Speaker 1>We're often talking about FISER because it very obviously it

0:07:51.720 --> 0:07:55.920
<v Speaker 1>was first out of the gate, and understandably this allowed

0:07:56.080 --> 0:07:59.000
<v Speaker 1>to make these kinds of deals with the governments of

0:07:59.040 --> 0:08:02.400
<v Speaker 1>as we've been saying, Israel, obviously, the US and beyond.

0:08:03.120 --> 0:08:07.320
<v Speaker 1>But I'm wondering about the logistics of how it was

0:08:07.360 --> 0:08:11.520
<v Speaker 1>able to achieve this goal in terms of the amount

0:08:11.720 --> 0:08:15.280
<v Speaker 1>of investment it did of its own money in research

0:08:15.320 --> 0:08:21.320
<v Speaker 1>and development, how this has affected negotiating deals with governments

0:08:21.440 --> 0:08:26.760
<v Speaker 1>and and in particular setting prices for doses. Yeah, Visor

0:08:26.880 --> 0:08:31.080
<v Speaker 1>is unique in particular because they decided not to take

0:08:31.120 --> 0:08:34.080
<v Speaker 1>money from Operation Warp Speed, which was the US government

0:08:34.480 --> 0:08:37.960
<v Speaker 1>program that gave money to manufacturers in order to help

0:08:38.000 --> 0:08:43.160
<v Speaker 1>spur vaccine development and invest in manufacturing, etcetera. Visor didn't

0:08:43.280 --> 0:08:47.080
<v Speaker 1>didn't need that money, but arguably other large companies that

0:08:47.120 --> 0:08:49.520
<v Speaker 1>didn't need that money participated and took some and so

0:08:49.600 --> 0:08:52.840
<v Speaker 1>that was sort of a public private partnership, if you will,

0:08:52.880 --> 0:08:56.079
<v Speaker 1>just to get vaccines going. And the US created essentially

0:08:56.120 --> 0:08:59.200
<v Speaker 1>created a market for vaccines. And what they did, though,

0:08:59.520 --> 0:09:01.600
<v Speaker 1>was there with the US, was that the US had

0:09:01.640 --> 0:09:04.319
<v Speaker 1>an advanced purchase order, so the US was going to

0:09:04.360 --> 0:09:06.120
<v Speaker 1>be able to buy something around the tune of two

0:09:06.160 --> 0:09:08.360
<v Speaker 1>billion dollars worth of vaccine. So the US put money

0:09:08.400 --> 0:09:10.320
<v Speaker 1>on the table and Fiser had a market. And that's

0:09:10.320 --> 0:09:13.640
<v Speaker 1>really important too. It's not insignificant. It still means that

0:09:13.880 --> 0:09:16.560
<v Speaker 1>they're incentivized to create a vaccine because there's someone who's

0:09:16.559 --> 0:09:17.760
<v Speaker 1>on the other end who's going to buy it if

0:09:17.800 --> 0:09:19.760
<v Speaker 1>it works. But it's not the same thing as the

0:09:19.760 --> 0:09:22.720
<v Speaker 1>government being involved in their day to day getting reports

0:09:22.720 --> 0:09:25.400
<v Speaker 1>and updates on their manufacturing. And I think this explains

0:09:25.400 --> 0:09:27.360
<v Speaker 1>some of the snags they hit, at least in the US,

0:09:27.520 --> 0:09:30.559
<v Speaker 1>because the government didn't have the insight into their manufacturing

0:09:30.559 --> 0:09:33.960
<v Speaker 1>that they did with their competitors. So for for Fiser,

0:09:34.040 --> 0:09:36.800
<v Speaker 1>they've said they spent about two billion dollars developing this

0:09:37.000 --> 0:09:40.880
<v Speaker 1>drugs are vaccines very expensive to develop, especially the trials,

0:09:40.920 --> 0:09:43.440
<v Speaker 1>the huge trials, which is why a lot of their

0:09:43.440 --> 0:09:47.120
<v Speaker 1>competitors would have taken money from the government. So Fiser

0:09:47.200 --> 0:09:49.320
<v Speaker 1>basically stood a bit apart from the pack and that

0:09:49.360 --> 0:09:52.680
<v Speaker 1>did allow it to negotiate in a different way, perhaps

0:09:52.760 --> 0:09:54.720
<v Speaker 1>even allowed it to go around the world and start

0:09:54.760 --> 0:09:58.559
<v Speaker 1>striking contracts quite early, because say Maderna, for example, which

0:09:58.679 --> 0:10:01.560
<v Speaker 1>was authorized by the d at the same time as Visor,

0:10:01.760 --> 0:10:05.120
<v Speaker 1>just around the same time, they had taken substantially more

0:10:05.200 --> 0:10:08.160
<v Speaker 1>government government money and they have not done the number

0:10:08.160 --> 0:10:10.000
<v Speaker 1>of deals that Viser has done around the world. But

0:10:10.080 --> 0:10:13.720
<v Speaker 1>they're also a smaller company. Advisor is already globally, already

0:10:13.720 --> 0:10:17.000
<v Speaker 1>has a global footprint, so they had that advantage, and

0:10:17.040 --> 0:10:21.280
<v Speaker 1>that brings up an interesting question about profit. What has

0:10:21.679 --> 0:10:25.480
<v Speaker 1>Flier said regarding how much it is expecting to make

0:10:25.679 --> 0:10:29.240
<v Speaker 1>from its vaccines and how does this contrast perhaps with

0:10:29.440 --> 0:10:32.600
<v Speaker 1>some of the other drugmakers, say Maderna and whatnot. So

0:10:32.840 --> 0:10:37.640
<v Speaker 1>Fiser has said it expects initial profit margins in the

0:10:37.720 --> 0:10:41.439
<v Speaker 1>high twenty percent range, which is high for a vaccine

0:10:42.200 --> 0:10:44.680
<v Speaker 1>during the pandemic. This is they're they're looking at it

0:10:44.720 --> 0:10:48.199
<v Speaker 1>in terms of pandemic pricing, that they could look at

0:10:48.240 --> 0:10:53.160
<v Speaker 1>increasing that price after the pandemic is over, when people

0:10:53.200 --> 0:10:55.480
<v Speaker 1>have a choice of what vaccine they want and they

0:10:55.520 --> 0:11:00.079
<v Speaker 1>believe they have, you know, high brand recognition, why be

0:11:00.160 --> 0:11:03.800
<v Speaker 1>regarded as a very highly effective vaccine and that people

0:11:03.800 --> 0:11:07.880
<v Speaker 1>will want it over some of the other vaccines. In contrast,

0:11:07.960 --> 0:11:12.600
<v Speaker 1>you have manufacturers like Astra Zenica that has promised to

0:11:13.000 --> 0:11:15.920
<v Speaker 1>sell the vaccine globally on a not for profit basis

0:11:16.080 --> 0:11:19.360
<v Speaker 1>for just a couple of dollars of dose. UM Johnson

0:11:19.360 --> 0:11:23.600
<v Speaker 1>and Johnson has also UH promised to do that sell

0:11:23.640 --> 0:11:26.240
<v Speaker 1>it on a not for profit basis. And you know,

0:11:26.760 --> 0:11:30.439
<v Speaker 1>the way this really comes to the four is looking

0:11:30.480 --> 0:11:33.679
<v Speaker 1>at how all these drug manufacturers have interacted with Kovacs,

0:11:33.840 --> 0:11:38.120
<v Speaker 1>the World Health Organization backed facility to distribute vaccines to

0:11:38.160 --> 0:11:41.840
<v Speaker 1>low income countries uh Visor. At the end of January,

0:11:42.160 --> 0:11:46.400
<v Speaker 1>UM did a deal with CoV X to sell forty

0:11:46.400 --> 0:11:50.239
<v Speaker 1>million doses, which is about two percent of visors projected

0:11:50.240 --> 0:11:54.400
<v Speaker 1>output this year. And to put that into context, Astra

0:11:54.679 --> 0:11:57.640
<v Speaker 1>did a deal for a hundred and seventy million doses

0:11:57.720 --> 0:12:00.559
<v Speaker 1>and Johnson and Johnson has a preliminary co vacs deal

0:12:01.400 --> 0:12:06.120
<v Speaker 1>for five million doses um. And there's another deal that

0:12:06.200 --> 0:12:09.640
<v Speaker 1>Covex did with the Serum Institute of India that is

0:12:09.679 --> 0:12:13.480
<v Speaker 1>producing the Astrosonica vaccine again for just a few dollars

0:12:13.480 --> 0:12:16.400
<v Speaker 1>of dose. So that sort of puts Fiser into a

0:12:16.520 --> 0:12:19.760
<v Speaker 1>very different league in terms of COVID vaccines and how

0:12:19.840 --> 0:12:22.200
<v Speaker 1>much they're likely to make from them. And just to

0:12:22.280 --> 0:12:24.680
<v Speaker 1>add to that, the top line number here is that

0:12:24.760 --> 0:12:29.360
<v Speaker 1>Fiser has said they expect revenue of fifteen billion dollars

0:12:29.400 --> 0:12:33.160
<v Speaker 1>this year, and that doesn't that includes the contracts they've

0:12:33.200 --> 0:12:37.280
<v Speaker 1>already struck or bakes in the contracts they anticipate. So

0:12:37.320 --> 0:12:39.680
<v Speaker 1>there's an ability for them to now continue to make

0:12:40.120 --> 0:12:43.200
<v Speaker 1>deals around the world and make more than fifteen billion.

0:12:43.200 --> 0:12:44.880
<v Speaker 1>They're not going to take home fifteen billion. They have

0:12:44.880 --> 0:12:47.960
<v Speaker 1>a partnership with bion Tech. Just to be clear, fifteen

0:12:47.960 --> 0:12:50.240
<v Speaker 1>billion dollars makes it among one of the biggest selling

0:12:50.320 --> 0:12:52.800
<v Speaker 1>drugs in the world, and that never happens right out

0:12:52.800 --> 0:12:55.040
<v Speaker 1>of the gate. Drug companies never come out of the

0:12:55.080 --> 0:12:58.000
<v Speaker 1>gate with a huge selling product. They usually come out

0:12:58.040 --> 0:13:00.800
<v Speaker 1>and takes years to get to these levels. So first, viser,

0:13:00.840 --> 0:13:06.120
<v Speaker 1>it's extraordinary revenue and income boost. Returning to the question

0:13:06.480 --> 0:13:10.920
<v Speaker 1>of Viser CEO Borla, what are your reactions, let's say,

0:13:10.960 --> 0:13:14.400
<v Speaker 1>to to an accusation that that someone like Borla, a

0:13:14.480 --> 0:13:18.920
<v Speaker 1>CEO of a drugmaker, shouldn't be wielding this amount of

0:13:19.000 --> 0:13:23.400
<v Speaker 1>power in terms of you know, supply and cost of vaccines.

0:13:23.440 --> 0:13:25.640
<v Speaker 1>I mean, you know, he's not a public or an

0:13:25.640 --> 0:13:28.760
<v Speaker 1>elected official, but you know he at the end of

0:13:28.760 --> 0:13:32.319
<v Speaker 1>the day is making some of the most important decisions

0:13:32.400 --> 0:13:36.160
<v Speaker 1>in a global health crisis. I think the real issue

0:13:36.400 --> 0:13:41.520
<v Speaker 1>is that most people and global public health don't think

0:13:41.600 --> 0:13:45.640
<v Speaker 1>that this is how we should be fighting the pandemic.

0:13:46.040 --> 0:13:49.640
<v Speaker 1>This is not the best way to end the pandemic

0:13:49.760 --> 0:13:52.920
<v Speaker 1>and to bring infection rates down around the world. But

0:13:53.400 --> 0:13:56.079
<v Speaker 1>the fact of the matter is that Fiser, together with

0:13:56.120 --> 0:13:59.040
<v Speaker 1>bion Tech and it's brilliant scientists, stepped up to the

0:13:59.080 --> 0:14:03.920
<v Speaker 1>plate and developed an incredibly effective vaccine. The question I

0:14:04.000 --> 0:14:07.640
<v Speaker 1>think is um whether or not it ought to have

0:14:07.720 --> 0:14:12.200
<v Speaker 1>been following a more uh not for profit approach like

0:14:12.240 --> 0:14:15.520
<v Speaker 1>some of the other vaccine developers during the pandemic. And

0:14:15.559 --> 0:14:18.559
<v Speaker 1>I think that is that would have made it easier

0:14:19.000 --> 0:14:22.840
<v Speaker 1>to get the vaccine out more widely, made it perhaps

0:14:22.880 --> 0:14:27.080
<v Speaker 1>easier for um the likes of covacs to buy more

0:14:27.120 --> 0:14:31.640
<v Speaker 1>doses or for other countries to do bilateral deals. But

0:14:31.800 --> 0:14:34.400
<v Speaker 1>you know, when you think about how we might fight

0:14:34.440 --> 0:14:38.200
<v Speaker 1>the next pandemic um and when governments are putting up

0:14:38.240 --> 0:14:41.800
<v Speaker 1>money for research and development, whether or not there are

0:14:41.840 --> 0:14:44.720
<v Speaker 1>more strings attached so that governments have a bit more

0:14:44.760 --> 0:14:48.160
<v Speaker 1>control when some of these drugs get to the market.

0:14:48.560 --> 0:14:51.080
<v Speaker 1>I think too, this is sort of a fundamental question

0:14:51.120 --> 0:14:54.920
<v Speaker 1>about capitalism and healthcare, right, and it's come up in

0:14:55.080 --> 0:14:58.240
<v Speaker 1>every iteration of analyzing the U S health care system

0:14:58.280 --> 0:15:01.240
<v Speaker 1>when you overlay the need for a company to make

0:15:01.280 --> 0:15:05.600
<v Speaker 1>profits because it's answering to shareholders and the reality that

0:15:05.680 --> 0:15:10.280
<v Speaker 1>these drugs are vaccines, are life saving, and therefore should

0:15:10.280 --> 0:15:12.960
<v Speaker 1>there be you know, someone else in charge. And so

0:15:13.520 --> 0:15:16.320
<v Speaker 1>the Kovac's plan obviously didn't pan out. There have been

0:15:16.320 --> 0:15:18.520
<v Speaker 1>other examples of this. The w h I wanted a

0:15:18.520 --> 0:15:22.400
<v Speaker 1>patent pool that didn't exactly pan out, because pharma companies

0:15:22.440 --> 0:15:24.240
<v Speaker 1>need to own that i P in order to make

0:15:24.240 --> 0:15:27.880
<v Speaker 1>money off these products in future years. So I think

0:15:27.920 --> 0:15:31.200
<v Speaker 1>what this story highlights is something that's really chronic in nature,

0:15:31.640 --> 0:15:35.120
<v Speaker 1>in that we have this capitalist healthcare system and when

0:15:35.160 --> 0:15:38.520
<v Speaker 1>it comes to the vaccine in public health, it just

0:15:38.560 --> 0:15:40.720
<v Speaker 1>appears to be a mismatch. But how do we frain

0:15:40.800 --> 0:15:42.880
<v Speaker 1>that in how do we change that? And that's really

0:15:42.920 --> 0:15:51.720
<v Speaker 1>the question that was Stephanie Baker and Cynthia Coons. And

0:15:51.760 --> 0:15:54.120
<v Speaker 1>that's it for our show today. For coverage of the

0:15:54.160 --> 0:15:58.080
<v Speaker 1>outbreak from one bureaus around the world, visit Bloomberg dot

0:15:58.120 --> 0:16:02.360
<v Speaker 1>com slash coronavirus and if you like the show, please

0:16:02.440 --> 0:16:05.280
<v Speaker 1>leave us a review and a rating on Apple Podcasts

0:16:05.360 --> 0:16:08.600
<v Speaker 1>or Spotify. It's the best way to help more listeners

0:16:08.800 --> 0:16:13.080
<v Speaker 1>find our global reporting. The Prognosis Daily edition is produced

0:16:13.120 --> 0:16:17.440
<v Speaker 1>by to for Foreheads, Magnus Henrickson and me Laura Carlson.

0:16:18.080 --> 0:16:22.320
<v Speaker 1>Today's main story was reported by Stephanie Baker and Cynthia Coon's.

0:16:23.040 --> 0:16:26.920
<v Speaker 1>Original music by Leo Cedrin. Our editors are Rick Shine

0:16:27.080 --> 0:16:31.720
<v Speaker 1>and Francesca Levi. Francesco Levi is Bloomberg's head of podcasts.

0:16:32.240 --> 0:16:33.080
<v Speaker 1>Thanks for listening.